Financials data is unavailable for this security.
View more
Year on year Organon & Co had relatively flat revenues (6.17bn to 6.26bn), though the company grew net income 11.56% from 917.00m to 1.02bn.
Gross margin | 58.59% |
---|---|
Net profit margin | 15.76% |
Operating margin | 10.32% |
Return on assets | 8.65% |
---|---|
Return on equity | -- |
Return on investment | 11.12% |
More ▼
Cash flow in USDView more
In 2023, Organon & Co did not generate a significant amount of cash. However, the company earned 799.00m from its operations for a Cash Flow Margin of 12.76%. In addition the company used 260.00m on investing activities and also paid 569.00m in financing cash flows.
Cash flow per share | 4.86 |
---|---|
Price/Cash flow per share | 4.23 |
Book value per share | 0.5593 |
---|---|
Tangible book value per share | -19.97 |
More ▼
Balance sheet in USDView more
Current ratio | 1.64 |
---|---|
Quick ratio | 1.17 |
Total debt/total equity | 60.11 |
---|---|
Total debt/total capital | 0.9836 |
More ▼
Growth rates in USD
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 11.08%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg) | 2.72% |
---|---|
Div growth rate (5 year) | -- |
Payout ratio (TTM) | 29.70% |
EPS growth(5 years) | -14.04 |
---|---|
EPS (TTM) vs TTM 1 year ago | 31.77 |
More ▼